The global CBD gummies market size was valued at USD 1.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 30.7% from 2021 to 2028. CBD (Cannabidiol) gummies are receiving immense popularity among consumers owing to their exceptional pain relief, anti-depressant, anti-anxiety, and neuroprotective properties, which are expected to fuel the growth of the market over the forecast period. During the COVID-19 pandemic, people around the globe focused on the essentials of daily life. Governments across the globe have also put restrictions on the export and import of non-essential items, such as CBD, unprocessed hemp, and isolate. Hence, during the COVID-19 pandemic, the market for CBD gummies has witnessed slow growth across the globe.
A wide range of pain medications are available in the global market such as aspirin, acetaminophen, ibuprofen, and naproxen, and all of these painkillers have very serious side effects. On the other hand, these products can help in reducing chronic pain by improving endocannabinoid receptor activity, reducing inflammation, and acting together with neurotransmitters. Such health benefits are anticipated to fuel their demand over the forecast period.
However, CBD gummies have evolved as an important method to cope with stress and the product has become essential among consumers who have been enjoying it for a while. Thus, these consumers continue to contribute to revenue growth. Further, an increase in the stress levels of the common masses due to the outbreak of the pandemic can contribute to higher demand for CBD gummies.
The increasing pressure among working individuals and even students has resulted in a gradual rise in anxiety and depression across the globe. According to statistics provided by the Anxiety and Depression Association of America (ADAA), in 2019, anxiety is the most common mental illness in the U.S., with more than 40 million adults of age 18 and older affected by this disorder only in the U.S. With the increasing prevalence of anxiety and depression, the demand for CBD gummies is anticipated to receive a boost over the forecast period.
A rise in the legalization of cannabis for medical and recreational purposes is a major factor supporting the demand for cannabidiol gummies. No traces of tetrahydrocannabinol (THC) content in the product is expected to further drive the demand among consumers interested in the consumption of the product for medical purposes.
The low concentrated CBD gummies held the largest share of 90.2% in 2020 and are expected to maintain their lead over the forecast period. First-time buyers prefer low CBD content gummies ranging from 1 mg to 20 mg CBD per gummy. Most of the companies including Hemp Bombs, Green Roads, Charlotte’s Web, and CV Sciences, Inc. offer low content gummies containing 5 mg, 10 mg, and 15 mg CBD per gummy.
High concentrated gummies are projected to register the fastest CAGR of 34.7% from 2021 to 2028. The increasing awareness among consumers regarding the advantages of marijuana edibles for the treatment of sleep disorders is anticipated to fuel the segment growth in the near future. Consumers consume these high-potency CBD gummies for an extra boost of CBD. Available in various flavors in the market, these products help people relax and feel calm from their hectic lifestyles, along with reducing stress and anxiety and enhancing mood.
The offline distribution channel was the largest segment with a share of 56.4% in 2020 and is expected to witness the fastest growth over the forecast period. The overall sales through offline channels dropped drastically owing to the closure of all the brick and mortar stores due to the pandemic across the globe. Moreover, there is a high penetration of head shops around most large cities owing to which head shops enjoy a significant existing clientele and a loyal local customer base. Consumers prefer offline stores for purchasing authentic and quality products. Retail pharmacies provide CBD products with a specific prescription.
The online distribution channel is expected to register a growth rate of 17.2% from 2021 to 2028. The hassle-free shopping experience offered by Amazon and other online platforms is expected to drive the segment. Easy payment methods, which fit into the regulatory standards of different countries, have made operations easier. Major manufacturers of CBD gummies focus on online distribution channels to reach more consumers.
North America held the largest share of 62.0% in 2020. In the U.S., the legalization of cannabis for medical and recreational purposes is among the top factors driving the market. The Farm Bill of 2018 legalized the growth of industrial hemp as long as plants have a maximum THC content of 0.3%. CBD gummies are legal in all 50 states in the country as long as they are derived from hemp. These factors are foreseen to drive the demand for CBD gummies over the forecast period.
Europe is expected to register the fastest CAGR of 31.0% from 2021 to 2028. This is attributed to the rise in the number of cannabis consumers. CBD products are legal in almost every European country, but there are some exceptions. In January 2019, the European Commission decided to review the Novel Food requirements to clarify CBD regulations.
The market players face intense competition, especially from the top companies in the market as they have a large consumer base, strong brand recognition, and vast distribution networks and they are continuously expanding their presence across major markets. For instance, in February 2021, Champs, Inc. signed an exclusive distribution agreement with First Capital Venture Co., a subsidiary of PotNetwork Holdings and the owner of Diamond CBD. This cooperative effort is to bring athlete-approved products to the market that will widen the opportunity for Diamond CBD.
Companies have been implementing various expansion strategies, such as mergers & acquisitions, new product launches, and production capacity expansion, to gain a competitive advantage over other players. For instance, in August 2020, CV Sciences, Inc. launched its Happy Lane product line that includes soft gels, roll-ons, liquids, chews, and gummies. These are distributed through the convenience store channel and select natural products retailers across the U.S. Some prominent players in the global CBD gummies market include: -
CV Sciences, Inc.
Dixie Brands
Reliva CBD
Sunday Scaries
Green Roads
Medix CBD
Hemp Bombs
PureKana
Diamond CBD
Premium Jane
Report Attribute |
Details |
Market size value in 2021 |
USD 2.1 billion |
Revenue forecast in 2028 |
USD 13.9 billion |
Growth Rate |
CAGR of 30.7% from 2021 to 2028 |
Base year for estimation |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Concentration, distribution channel, region |
Regional scope |
North America; Europe; RoW |
Country scope |
U.S.; Canada; Mexico; Germany; U.K.; France; Australia |
Key companies profiled |
CV Sciences, Inc.; Dixie Brands; Reliva CBD; Sunday Scaries; Green Roads; Medix CBD; Hemp Bombs; PureKana; Diamond CBD; Premium Jane |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global CBD gummies market report on the basis of concentration, distribution channel, and region:
Concentration Outlook (Revenue, USD Million, 2016 - 2028)
High
Low
Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)
Online
Offline
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
RoW
Australia
b. The global CBD gummies market size was estimated at USD 1.64 billion in 2020 and is expected to reach USD 13.9 billion by 2028.
b. The global CBD gummies market is expected to grow at a compound annual growth rate of 30.7% from 2021 to 2028 to reach USD 13.9 billion by 2028.
b. The low concentrated CBD gummies held the largest share of 90.2% in 2020.
b. The offline distribution channel dominated the global cannabidiol gummies market with a share of 56.4% in 2020.
b. North America dominated the CBD gummies market with a share of 62.0% in 2020. This is attributed to the legalization of CBD products in the U.S. and Canada.
b. Some key players operating in the CBD gummies market include CV Sciences; Dixie Brands Inc.; Reliva CBD Wellness; Sunday Scaries; Green Roads CBD; Medix CBD; Hemp Bombs; Pure Kana; Diamond CBD and Premium Jane.
b. Key factors that are driving the CBD gummies market growth include increasing use of cannabis for the treatment of neurological disorders, psychiatric disorders, and cancer along with pain control.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."